Genetic pathways in disorders of epidermal differentiation

Trends in Genetics

Volumn 29, Issue 1, 2013, Pages 31-40

  Lopez Pajares, Vanessa ^a,b   Yan, Karen ^a,b   Zarnegar, Brian J ^a,b   Jameson, Katherine L ^a,b   Khavari, Paul A ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Differentiation; Epidermis; Genetics; Keratinocyte; Skin disease

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NEUROFIBROMIN; NOTCH RECEPTOR; P CADHERIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

CADIO FACIO CUTANEOUS SYNDROME; CLEFT LIP PALATE; CONGENITAL PACHYONYCHIA; COSTELLO SYNDROME; COWDEN SYNDROME; DARIER DISEASE; EPIDERMAL DIFFERENTIATION DISORDER; EPIDERMOLYSIS BULLOSA; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPIDERMOLYSIS BULLOSA SIMPLEX; ERYTHROKERATODERMIA VARIABILIS; GENE MUTATION; GENETICS; HAILEY HAILEY DISEASE; HUMAN; ICHTHYOSIS VULGARIS; KERATODERMA HEREDITARIUM MUTILANS; LAMELLAR ICHTHYOSIS; LIPID METABOLISM; NETHERTON DISEASE; NONHUMAN; NOONAN SYNDROME; PALMOPLANTAR KERATODERMA; PILOMATRIXOMA; PRIORITY JOURNAL; REVIEW; SCLEROSING CHOLANGITIS; SEBACEOUS NEVUS; SKIN ABRASION; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; X LINKED ICHTHYOSIS;

ANIMALS; CELL DIFFERENTIATION; EPIDERMIS; GENE REGULATORY NETWORKS; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; SKIN DISEASES;

EID: 84871688110     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2012.10.005     Document Type: Review

References (89)

1. Blanpain C., Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat. Rev. Mol. Cell Biol. 2009, 10:207-217.
2. Chamcheu J.C., et al. Keratin gene mutations in disorders of human skin and its appendages. Arch. Biochem. Biophys. 2011, 508:123-137.
3. Arin M.J., et al. Identification of novel and known KRT5 and KRT14 mutations in 53 patients with epidermolysis bullosa simplex: correlation between genotype and phenotype. Br. J. Dermatol. 2010, 162:1365-1369.
4. Bchetnia M., et al. Expression signature of epidermolysis bullosa simplex. Hum. Genet. 2012, 131:393-406.
5. Sawamura D., et al. Overview of epidermolysis bullosa. J. Dermatol. 2010, 37:214-219.
6. Walko G., et al. Targeted proteolysis of plectin isoform 1a accounts for hemidesmosome dysfunction in mice mimicking the dominant skin blistering disease EBS-Ogna. PLoS Genet. 2011, 7:e1002396.
7. Arin M.J., et al. Expanding the keratin mutation database: novel and recurrent mutations and genotype-phenotype correlations in 28 patients with epidermolytic ichthyosis. Br. J. Dermatol. 2011, 164:442-447.
8. Wallace L., et al. Deletion of K1/K10 does not impair epidermal stratification but affects desmosomal structure and nuclear integrity. J. Cell Sci. 2012, 125:1750-1758.
9. Choate K.A., et al. Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science 2010, 330:94-97.
10. Tu C-L., et al. Inactivation of the calcium sensing receptor inhibits E-cadherin-mediated cell-cell adhesion and calcium-induced differentiation in human epidermal keratinocytes. J. Biol. Chem. 2008, 283:3519-3528.
11. Tu C-L., et al. Ablation of the calcium-sensing receptor in keratinocytes impairs epidermal differentiation and barrier function. J. Invest. Dermatol. 2012, 132:2350-2359.
12. Celli A., et al. Endoplasmic reticulum Ca2+ depletion activates XBP1 and controls terminal differentiation in keratinocytes and epidermis. Br. J. Dermatol. 2011, 164:16-25.
13. Sakuntabhai A., et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat. Genet. 1999, 21:271-277.
14. Hu Z., et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat. Genet. 2000, 24:61-65.
15. Leinonen P.T., et al. Reevaluation of the normal epidermal calcium gradient, and analysis of calcium levels and ATP receptors in Hailey-Hailey and Darier epidermis. J. Invest. Dermatol. 2009, 129:1379-1387.
16. Foggia L., et al. Activity of the hSPCA1 Golgi Ca2+ pump is essential for Ca2+-mediated Ca2+ response and cell viability in Darier disease. J. Cell Sci. 2006, 119:671-679.
17. Pani B., et al. Up-regulation of transient receptor potential canonical 1 (TRPC1) following sarco(endo)plasmic reticulum Ca2+ ATPase 2 gene silencing promotes cell survival: a potential role for TRPC1 in Darier's disease. Mol. Biol. Cell 2006, 17:4446-4458.
18. Celli A., et al. SERCA2-controlled Ca2+-dependent keratinocyte adhesion and differentiation is mediated via the sphingolipid pathway: a therapeutic target for Darier's disease. J. Invest. Dermatol. 2012, 132:1188-1195.
19. Hong J.H., et al. K6PC-5, a direct activator of sphingosine kinase 1, promotes epidermal differentiation through intracellular Ca2+ signaling. J. Invest. Dermatol. 2008, 128:2166-2178.
20. Morita K., et al. Tight junctions in epidermis: from barrier to keratinization. Eur. J. Dermatol. 2011, 21:12-17.
21. Petrof G., et al. Desmosomal genodermatoses. Br. J. Dermatol. 2012, 166:36-45.
22. Bergman R., et al. Disadhesion of epidermal keratinocytes: a histologic clue to palmoplantar keratodermas caused by DSG1 mutations. J. Am. Acad. Dermatol. 2010, 62:107-113.
23. Li D., et al. Lack of plakoglobin in epidermis leads to keratoderma. J. Biol. Chem. 2012, 287:10435-10443.
24. Sumigray K.D., et al. Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis. J. Cell Biol. 2011, 194:631-642.
25. Brancati F., et al. Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome. Am. J. Hum. Genet. 2010, 87:265-273.
26. Blaydon D.C., et al. Mutations in CSTA, encoding cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion. Am. J. Hum. Genet. 2011, 89:564-571.
27. Elias P.M., et al. Ichthyoses. Curr. Probl. Dermatol. 2010, 39:1-29.
28. Fehrenschild D., et al. TCF/Lef1-mediated control of lipid metabolism regulates skin barrier function. J. Invest. Dermatol. 2011, 132:337-345.
29. Yu Z., et al. The Grainyhead-like epithelial transactivator Get-1/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4. Dev. Biol. 2006, 299:122-136.
30. Segre J.A., et al. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 1999, 22:356-360.
31. Brown S.J., McLean W.H.I. One remarkable molecule: filaggrin. J. Invest. Dermatol. 2012, 132:751-762.
32. Roberson E.D.O., Bowcock A.M. Psoriasis genetics: breaking the barrier. Trends Genet. 2010, 26:415-423.
33. Fischer J. Autosomal recessive congenital ichthyosis. J. Invest. Dermatol. 2009, 129:1319-1321.
34. Ekholm I.E., et al. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process?. J. Invest. Dermatol. 2000, 114:56-63.
35. Akiyama M. ABCA12 mutations and autosomal recessive congenital ichthyosis: a review of genotype/phenotype correlations and of pathogenetic conceptsa. Hum. Mutat. 2010, 31:1090-1096.
36. Jiang Y.J., et al. PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. J. Invest. Dermatol. 2007, 128:104-109.
37. Jiang Y.J., et al. Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor Δ in human keratinocytes. J. Biol. Chem. 2009, 284:18942-18952.
38. Yang L., et al. Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors. Cancer Res. 2005, 65:8671-8678.
39. Hoot K.E., et al. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J. Clin. Invest. 2008, 118:2722-2732.
40. Zhang J.Y., et al. NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev. 2004, 18:17-22.
41. Suzuki A., et al. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res. 2003, 63:674-681.
42. Demehri S., et al. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 2009, 16:55-66.
43. Truong A.B., et al. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev. 2006, 20:3185-3197.
44. Su X., et al. Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. EMBO J. 2009, 28:1904-1915.
45. Koster M.I. p63 in skin development and ectodermal dysplasias. J. Invest. Dermatol. 2010, 130:2352-2358.
46. Clements S.E., et al. Mutations in AEC syndrome skin reveal a role for p63 in basement membrane adhesion, skin barrier integrity and hair follicle biology. Br. J. Dermatol. 2012, 167:134-144.
47. Ferone G., et al. Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome. EMBO Mol. Med. 2012, 4:192-205.
48. Birnbaum R.Y., et al. Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein. Nat. Genet. 2006, 38:749-751.
49. Yang C-F., et al. A promoter sequence variant of ZNF750 is linked with familial psoriasis. J. Invest. Dermatol. 2008, 128:1662-1668.
50. Sen G.L., et al. ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation. Dev. Cell 2012, 22:669-677.
51. Zarnegar B.J., et al. Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63. Am. J. Hum. Genet. 2012, 91:435-443.
52. Wu M.Y., Hill C.S. Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev. Cell 2009, 16:329-343.
53. Fuxe J., et al. Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010, 9:2363-2374.
54. Qiao W., et al. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin. Oncogene 2006, 25:207-217.
55. Descargues P., et al. IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:2487-2492.
56. Goudie D.R., et al. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat. Genet. 2011, 43:365-369.
57. Senftleben U., et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001, 293:1495-1499.
58. Hu Y., et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 1999, 284:316-320.
59. Liu B., et al. A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17202-17207.
60. Maeda G., et al. Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression. Clin. Cancer Res. 2007, 13:5041-5047.
61. Park E., et al. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Cancer Res. 2007, 67:9158-9168.
62. Nelson D.L. NEMO, NFkappaB signaling and incontinentia pigmenti. Curr. Opin. Genet. Dev. 2006, 16:282-288.
63. Keller M.D., et al. Hypohidrotic ectodermal dysplasia and immunodeficiency with coincident NEMO and EDA mutations. Front. Immunol. 2011, 2:61.
64. Salhi A., et al. Multiple familial trichoepithelioma caused by mutations in the cylindromatosis tumor suppressor gene. Cancer Res. 2004, 64:5113-5117.
65. Tinkle C.L., et al. New insights into cadherin function in epidermal sheet formation and maintenance of tissue integrity. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15405-15410.
66. Adaimy L., et al. Mutation in wnt10a is associated with an autosomal recessive ectodermal dysplasia: the Odonto-Onycho-Dermal dysplasia. Am. J. Hum. Genet. 2007, 81:821-828.
67. Nawaz S., et al. WNT10A missense mutation associated with a complete Odonto-Onycho-Dermal Dysplasia syndrome. Eur. J. Hum. Genet. 2009, 17:1600-1605.
68. Nguyen H., et al. Tcf3 governs stem cell features and represses cell fate determination in skin. Cell 2006, 127:171-183.
69. Nguyen H., et al. Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. Nat. Genet. 2009, 41:1068-1075.
70. Harris T.J.C., Tepass U. Adherens junctions: from molecules to morphogenesis. Nat. Rev. Mol. Cell Biol. 2010, 11:502-514.
71. Chan E.F., et al. A common human skin tumour is caused by activating mutations in beta-catenin. Nat. Genet. 1999, 21:410-413.
72. Malanchi I., et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 2008, 452:650-653.
73. Samuel M.S., et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011, 19:776-791.
74. Watt F.M., et al. Epidermal Notch signalling: differentiation, cancer and adhesion. Curr. Opin. Cell Biol. 2008, 20:171-179.
75. Wang X., et al. AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. J. Cell Biol. 2008, 183:37-48.
76. Demehri S., et al. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 2009, 16:55-66.
77. Restivo G., et al. IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. EMBO J. 2011, 30:4571-4585.
78. Wang N.J., et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:17761-17766.
79. Scholl F.A., et al. Mek1/2 MAPK kinases are essential for mammalian development, homeostasis, and Raf-Induced hyperplasia. Dev. Cell 2007, 12:615-629.
80. Forbes S.A., et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2010, 39:D945-D950.
81. Groesser L., et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat. Genet. 2012, 44:783-787.
82. Tidyman W., Rauen K. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr. Opin. Genet. Dev. 2009, 19:230-236.
83. Senawong T., et al. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options. Hum. Mol. Genet. 2008, 17:419-430.
84. Anastasaki C., et al. Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors. Hum. Mol. Genet. 2009, 18:2543-2554.
85. Niihori T., et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat. Genet. 2006, 38:294-296.
86. Schuhmacher A.J., et al. A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition. J. Clin. Invest. 2008, 118:2169-2179.
87. Calautti E., et al. Phosphoinositide 3-kinase signaling to akt promotes keratinocyte differentiation versus death. J. Biol. Chem. 2005, 280:32856-32865.
88. Darido C., et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN Loss and tumorigenesis. Cancer Cell 2011, 20:635-648.
89. Yao D., et al. Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21WAF-induced differentiation triggered by GSK3β inactivation and reduced AKT activity. J. Cell Sci. 2008, 121:1758-1769.